Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Business Overview: The Company operates in two primary segments: Oral, Personal, Household Surface and Fabric Care, and Pet Nutrition. Operations are organized geographically across North America, Latin America, Europe, and Asia/Africa. The Company competes in over 200 countries and territories.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Sales | $2,513.5 million | $2,348.4 million |
| Gross Profit | $1,399.6 million | $1,298.2 million |
| Gross Margin | 55.7% | 55.3% |
| Operating Profit | $531.3 million | $510.5 million |
| Operating Margin | 21.1% | 21.7% |
| Net Income | $338.5 million | $324.0 million |
| Diluted EPS | $0.59 | $0.56 |
| Net Cash from Operations | $371.3 million | $367.1 million |
| Cash and Equivalents (End of Period) | $271.5 million | $205.8 million |
| Total Debt (Current + Long-term) | $3,115.1 million | $3,002.9 million |
Material Changes vs. Prior Period
- Sales Growth: Worldwide sales increased 7.0% year-over-year, driven by a 3.0% unit volume gain, a 5.0% positive foreign exchange impact, and a 1.0% decrease in net selling prices. Excluding divested European detergent brands, sales grew 8.0% on 4.0% volume growth.
- Regional Performance:
- North America: Sales declined 3.5% due to volume declines and lower prices, though foreign exchange provided a 1.0% benefit. Operating profit fell 8%.
- Latin America: Sales rose 7.0% driven by 5.5% volume growth and price increases. Operating profit increased 6%.
- Europe: Sales surged 14.5% (19.0% excluding divestments) due to volume gains and a 13.5% currency impact. Operating profit grew 14%.
- Asia/Africa: Sales increased 11.0% on 6.0% volume growth and 9.0% currency benefits. Operating profit jumped 28%.
- Pet Nutrition: Sales grew 8.5% with 4.0% volume gains. Operating profit increased 9%.
- Expenses: Selling, general, and administrative (SG&A) expenses as a percentage of sales increased to 34.6% from 33.6%, driven by higher advertising, restructuring costs, and foreign currency contract losses.
- Restructuring: The Company recorded $1.5 million in incremental depreciation and made $7.7 million in cash payments related to restructuring. Total expected restructuring costs are approximately $70 million, with completion expected by end of 2004.
Guidance, Outlook, and Risks
- Outlook: Management anticipates common stock repurchases in the second half of 2004 will decline compared to 2003 levels. The Company continues to prioritize investments in higher margin businesses (Oral Care, Personal Care, Pet Nutrition).
- Acquisitions: In December 2003, the Company agreed to acquire GABA Holding AG, a European oral care company.
- Legal Contingencies:
- Brazil: The Company faces administrative and legal proceedings regarding the 1995 Kolynos acquisition. Issues include a Central Bank fine (approx. $90 million), tax assessments (approx. $40 million), and potential criminal charges against officers. Management intends to challenge these vigorously and believes they will prevail.
- IRS: The IRS has proposed an assessment challenging tax deductions for expatriate executive compensation for 1996-1998. The Company is pursuing an administrative appeal.
- Retirement Plans: The Company is evaluating the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 on its postretirement plans. In April 2004, voluntary contributions of $38.1 million were made to U.S. postretirement plans.
Investor Verification Checklist
- Verify the impact of foreign exchange rates on reported sales and operating profit, particularly in Europe and Asia/Africa.
- Monitor the resolution of Brazilian legal proceedings regarding the Kolynos acquisition, including potential fines and tax assessments.
- Track the progress and integration costs of the pending GABA Holding AG acquisition.
- Review the status of the IRS administrative appeal regarding expatriate executive compensation deductions.
- Assess the sustainability of volume growth in North America, which declined 3.0% in the quarter.